Top Searched Resources

A New Integrase Inhibitor – Bictegravir New drug application in the US for Bictegravir, Emtricitabine, Tenofovir Alafenamide single-tablet regimen

Gilead Sciences announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single tablet regimen containing bictegravir (BIC), a novel investigational integrase strand transfer inhibitor (formerly GS-9883), and emtricitabine (FTC)/tenofovir …

Looking for a Needle and Syringe Program?

In South East Queensland, our friends at QuIHN (Queensland Injectors Health Network) is a helpful place to go. QuIHN is a statewide, not for profit, and non-government health service which provides a variety of health services to illicit drug users throughout Queensland. The …

FDA Approves New Once-Daily HIV Med Isentress HD

The US FDA has approved a new once-daily version of Merck’s antiretroviral (ARV) Isentress, known as Isentress HD.  Until now, Isentress (raltegravir) had been available only as a twice-daily treatment. Treatment with Isentress HD entails taking two 600 mg tablets once …

Health Consumers Queensland Annual Forum

Queensland Positive People was invited by Health Consumers Queensland to showcase ‘Peer Navigation for People Living with HIV’ at their annual Forum in Townsville, Thursday May 18. The forum, tilted ‘Power and Passion: Culture change through consumer engagement and partnerships,’ showcased …

CROI 2017: Higher than Expected HCV Prevalence Among HIV- Gay Men in Amsterdam PrEP Program

An unexpectedly high number of HIV-negative gay and bisexual men taking pre-exposure prophylaxis (PrEP) in Amsterdam were found to have hepatitis C virus (HCV) infection, suggesting HCV is being transmitted sexually between men with and without HIV, according to a presentation …

ODEFSEY – A NEW TRIPLE COMBO PILL

ODEFSEY – a new combination pill containing rilpivirine (Edurant – an existing NNRTI), TAF (tenofovir alafenamide), and FTC (Emtriva – emtricitabine) was registered in Australia by Gilead Sciences in October 2016, and has now become available (from 01 May 2017) on …